ARVN Competitors & Alternatives
Compare Arvinas Inc with similar stocks in the same industry
Biotechnology
ARVN
Main Stock$7.58
Tradestie Score
51
Market Cap
$670.30M
Revenue Growth
-0.9%
Analyst Upside
+95.3%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$92.20
|
$492.21M | - | 51 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$41.79
|
$474.20M | 26.6 | 57 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$6.80
|
$468.01M | - | 56 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$18.24
|
$463.20M | - | 50 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$7.14
|
$457.09M | - | 57 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$4.98
|
$454.29M | - | 62 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$18.69
|
$448.32M | - | 60 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$24.15
|
$422.50M | - | 61 | Compare |
More ARVN Analysis
Data updated: Jun 13, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry